MTOR and Alzheimer disease: While p-mTOR is increased in the hippocampus of AD patients [25], we chose the midbrain since it would be directly comparable to the ex vivo studies (above) and also since T14 levels increase in the midbrain in a BRAAK stage dependent manner [7,8].